About CytoSolv
CytoSolv is a company based in Newport (United States) founded in 2009 was acquired by Semma Therapeutics in November 2015.. CytoSolv has raised $500 thousand across 5 funding rounds from investors including Semma Therapeutics, National Science Foundation and Slater Technology Fund. CytoSolv operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.
- Headquarter Newport, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$500 K (USD)
in 5 rounds
-
Latest Funding Round
$150 K (USD), Grant
Jan 01, 2013
-
Investors
Semma Therapeutics
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Semma Therapeutics
(Nov 16, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CytoSolv
CytoSolv has successfully raised a total of $500K across 5 strategic funding rounds. The most recent funding activity was a Grant round of $150 thousand completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $150,000
-
First Round
First Round
(09 Feb 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2013 | Amount | Grant - CytoSolv | Valuation |
investors |
|
| Sep, 2011 | Amount | Grant - CytoSolv | Valuation |
investors |
|
| Jan, 2011 | Amount | Grant - CytoSolv | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CytoSolv
CytoSolv has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Semma Therapeutics, National Science Foundation and Slater Technology Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC investments are directed toward US and UK companies.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Develops cell therapy treatments for neurodegenerative diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CytoSolv
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CytoSolv
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytosolv Comparisons
Competitors of CytoSolv
CytoSolv operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CytoSolv
When was CytoSolv founded?
CytoSolv was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is CytoSolv located?
CytoSolv is headquartered in Newport, United States. It is registered at Newport, Rhode Island, United States.
Is CytoSolv a funded company?
CytoSolv is a funded company, having raised a total of $500K across 5 funding rounds to date. The company's 1st funding round was a Grant of $150K, raised on Feb 09, 2010.
What does CytoSolv do?
CytoSolv was founded in 2009 in Newport, United States, as a biotech firm focused on encapsulating cell technology within the cell therapy sector. Initial efforts targeted therapies for diabetic foot ulcer wound healing, with operations later shifted toward broader encapsulating applications. The company was acquired by Semma Therapeutics on November 16, 2015, concluding its independent development activities.
Who are the top competitors of CytoSolv?
CytoSolv's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Who are CytoSolv's investors?
CytoSolv has 4 investors. Key investors include Semma Therapeutics, National Science Foundation, Slater Technology Fund, and Living Cell Technologies.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.